Venetoclax-based regimens in combination with trametinib for RAS-mutated relapsed or refractory myeloid malignancies

被引：3
|
作者：
Kevlicius, Lukas [1 ,2 ]
Cepulyte, Ruta [1 ]
Vasilevska, Dominika [2 ]
Griskevicius, Laimonas [1 ,2 ]
Zucenka, Andrius [1 ,2 ]
机构：
[1] Vilnius Univ Hosp Santaros Klinikos, Hematol Oncol & Transfus Med Ctr, Vilnius, Lithuania
[2] Vilnius Univ, Fac Med, Inst Clin Med, Vilnius, Lithuania
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / 06期
关键词：
D O I：
10.1038/s41409-022-01679-6
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1034 / 1037
页数：4
相关论文
共 50 条
  • [1] Venetoclax-based regimens in combination with trametinib for RAS-mutated relapsed or refractory myeloid malignancies
    Lukas Kevlicius
    Ruta Cepulyte
    Dominika Vasilevska
    Laimonas Griskevicius
    Andrius Zucenka
    Bone Marrow Transplantation, 2022, 57 : 1034 - 1037
  • [2] Venetoclax-Based Combination Regimens in Acute Myeloid Leukemia
    Goulart, Hannah
    Kantarjian, Hagop
    Pemmaraju, Naveen
    Daver, Naval
    Dinardo, Courtney D.
    Rausch, Caitlin R.
    Ravandi, Farhad
    Kadia, Tapan M.
    BLOOD CANCER DISCOVERY, 2025, 6 (01): : 23 - 37
  • [3] Differential Outcomes of Salvage with FLAG-IDA and Venetoclax-Based Regimens in Relapsed and Refractory Acute Myeloid Leukemia
    Bouligny, Ian M.
    Maher, Keri R.
    BLOOD, 2021, 138
  • [4] Venetoclax-based therapy in treatment-naive and relapsed/refractory acute myeloid leukemia
    Ravindra, Aditya
    Acharya, Luna
    Loeffler, Bradley
    Bell, Sarah L.
    Sutamtewagul, Grerk
    Dhakal, Prajwal
    CANCER RESEARCH, 2023, 83 (07)
  • [5] Venetoclax-based therapy in treatment-naïve and relapsed/refractory acute myeloid leukemia
    Ravindra, Aditya
    Acharya, Luna
    Loeffler, Bradley
    Mott, Sarah
    Sutamtewagul, Grerk
    Dhakal, Prajwal
    LEUKEMIA RESEARCH, 2023, 135
  • [6] Venetoclax in Combination with Decitabine or Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia Is Comparable to Alternative Regimens
    Miller, Jenn
    Shannon, Lindsey
    Finch, Amanda
    Altman, Jessica K.
    Wojenski, Daniel
    BLOOD, 2020, 136
  • [7] Clinical Experience of Venetoclax Combinations for Relapsed/Refractory Myeloid Malignancies
    Rausch, Caitlin R.
    DiNardo, Courtney D.
    Kadia, Tapan
    Takahashi, Koichi
    Jain, Nitin
    Benton, Christopher
    Thompson, Philip
    Ohanian, Maro
    Covert, Wendy
    Mace, Morgan
    Marx, Kayleigh R.
    Pemmaraju, Naveen
    Daver, Naval
    Jabbour, Elias
    Cortes, Jorge
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Konopleva, Marina
    Kantarjian, Hagop
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (10): : S4 - S5
  • [8] Venetoclax-Based Regimens for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting: A Retrospective Single-Center Experience
    Piccini, Matteo
    Pilerci, Sofia
    Merlini, Marta
    Grieco, Pietro
    Scappini, Barbara
    Bencini, Sara
    Peruzzi, Benedetta
    Caporale, Roberto
    Signori, Leonardo
    Pancani, Fabiana
    Vannucchi, Alessandro Maria
    Gianfaldoni, Giacomo
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (08)
  • [9] Venetoclax-based therapy for relapsed or refractory acute myeloid leukaemia following intensive induction chemotherapy
    Kristensen, Daniel Tuyet
    Brondum, Rasmus Froberg
    orskov, Andreas Due
    Marcher, Claus Werenberg
    Schollkopf, Claudia
    Sorensen, Anne Louise Tolboll
    Severinsen, Marianne Tang
    Bogsted, Martin
    Roug, Anne Stidsholt
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (04) : 573 - 582
  • [10] Outcomes of relapsed or refractory acute myeloid leukemia patients failing venetoclax-based salvage therapies
    Zucenka, Andrius
    Pileckyte, Regina
    Trociukas, Igoris
    Peceliunas, Valdas
    Vaitekenaite, Vilmante
    Maneikis, Kazimieras
    Davainis, Linas
    Zvirblis, Tadas
    Stoskus, Mindaugas
    Gineikiene, Egle
    Norvilas, Rimvydas
    Dirse, Vaidas
    Surauciute, Agne
    Zucenkiene, Emile
    Griskevicius, Laimonas
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (01) : 105 - 113
12345